These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 20537173)

  • 1. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
    Gandjbakhch F; Fajardy I; Ferré B; Dubucquoi S; Flipo RM; Roger N; Solau-Gervais E
    J Rheumatol; 2009 May; 36(5):881-6. PubMed ID: 19332633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis].
    Fan LY; Zong M; Lu TB; Yang L; Ding YY; Ma JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):57-61. PubMed ID: 19199253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to 'Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study'.
    Ikari K; Yano K; Yoshida S; Taniguchi A; Yamanaka H; Momohara S
    Arthritis Res Ther; 2014 Aug; 16(5):422. PubMed ID: 25263166
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
    Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K
    Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
    Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
    Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.
    Abd-Allah SH; el-Shal AS; Shalaby SM; Pasha HF; Abou el-Saoud AM; el-Najjar AR; el-Shahawy EE
    Joint Bone Spine; 2012 Mar; 79(2):124-8. PubMed ID: 21981985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
    Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Massarenti L; Enevold C; Damgaard D; Ødum N; Garred P; Frisch M; Shelef MA; Jacobsen S; Nielsen CH
    Front Immunol; 2021; 12():707690. PubMed ID: 34733271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
    Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
    Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
    Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.
    Snir O; Gomez-Cabrero D; Montes A; Perez-Pampin E; Gómez-Reino JJ; Seddighzadeh M; Klich KU; Israelsson L; Ding B; Catrina AI; Holmdahl R; Alfredsson L; Klareskog L; Tegnér J; Gonzalez A; Malmström V; Padyukov L
    Arthritis Res Ther; 2014 Aug; 16(4):414. PubMed ID: 25138370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.